Scholarlink

Objective <p>Severe fever with thrombocytopenia (SFTS) is a fatal emerging infectious disease. Co-infection, mainly with bacterial and fungal infections, in association with poorer outcomes in SFTS, but few studies have examined on viral infections. We aimed to investigate the prevalence of Epstein‒Barr virus (EBV) infection and its effects on the clinical features and mortality in patients with SFTS.</p> Methods <p>We retrospectively reviewed 104 patients with confirmed SFTS between 2011 and 2025, and analyzed their laboratory test results and clinical data.</p> Results <p>Of 104 SFTS patients, 48.10% had EBV infection. Compared to those without EBV infection, these patients were more likely to have bacterial infection in blood (<i>p</i> = 0.027), lower white blood cell (<i>p</i> &lt; 0.001) and neutrophil counts (<i>p</i> = 0.019), lower serum calcium (<i>p</i> = 0.043), and higher alanine aminotransferase (<i>p</i> = 0.013), adenosine deaminase (<i>p</i> = 0.018), and urinary protein (<i>p</i> = 0.005). Mortality rates were higher in EBV-infected patients (7 [14%] vs. 4 [7.4%], <i>p</i> = 0.275), though not statistically significant. In this study, decreased WBC count and elevated ALT level were independently associated with EBV infection in SFTS patients (OR = 0.391 [95% CI, 0.233–0.657] and 1.006 [95% CI, 1.001–1.011], both <i>p</i> &lt; 0.05).</p> Conclusions <p>SFTS patients are at high risk for EBV infection. Those with EBV infection exhibit more severe clinical manifestations, although short-term survival does not differ significantly. Decreased WBC count and elevated ALT are risk factors for EBV infection in SFTS patients. The need for targeted treatment of EBV infection remains uncertain.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The prevalence and influence of EBV infection in patients with severe fever with thrombocytopenia syndrome

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月22日

查看全文
  • Fangfang Geng,
  • Xiaoxiang Hu,
  • Yan Xu,
  • Tingting Xiao,
  • Meifang Yang,
  • Xuan Zhang,
  • Hong Zhao,
  • Jianhua Hu

摘要

Objective

Severe fever with thrombocytopenia (SFTS) is a fatal emerging infectious disease. Co-infection, mainly with bacterial and fungal infections, in association with poorer outcomes in SFTS, but few studies have examined on viral infections. We aimed to investigate the prevalence of Epstein‒Barr virus (EBV) infection and its effects on the clinical features and mortality in patients with SFTS.

Methods

We retrospectively reviewed 104 patients with confirmed SFTS between 2011 and 2025, and analyzed their laboratory test results and clinical data.

Results

Of 104 SFTS patients, 48.10% had EBV infection. Compared to those without EBV infection, these patients were more likely to have bacterial infection in blood (p = 0.027), lower white blood cell (p < 0.001) and neutrophil counts (p = 0.019), lower serum calcium (p = 0.043), and higher alanine aminotransferase (p = 0.013), adenosine deaminase (p = 0.018), and urinary protein (p = 0.005). Mortality rates were higher in EBV-infected patients (7 [14%] vs. 4 [7.4%], p = 0.275), though not statistically significant. In this study, decreased WBC count and elevated ALT level were independently associated with EBV infection in SFTS patients (OR = 0.391 [95% CI, 0.233–0.657] and 1.006 [95% CI, 1.001–1.011], both p < 0.05).

Conclusions

SFTS patients are at high risk for EBV infection. Those with EBV infection exhibit more severe clinical manifestations, although short-term survival does not differ significantly. Decreased WBC count and elevated ALT are risk factors for EBV infection in SFTS patients. The need for targeted treatment of EBV infection remains uncertain.